Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2019 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly EPS (Basic) came in at -$2.93 in Q1 2026, down 3.28% year-on-year from -$3.03 in Q1 2025, and up 46.8% quarter-over-quarter from -$5.51 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) EPS (Basic) (2019 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's EPS (Basic) history runs 8 years deep, the most recent figure standing at -$2.93 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 3.28% year-over-year to -$2.93 in Q1 2026; TTM through Mar 2026 was -$10.75, a 51.69% increase from a year earlier, with the FY2025 full-year figure at -$14.57, up 91.75% from the prior year.
- EPS (Basic) grew to -$2.93 in Q1 2026 per TNXP's latest filing, from -$5.51 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$2.84 in Q1 2025 and bottomed at -$32565.0 in Q1 2022.
- The 5-year median for EPS (Basic) is -$1928.4 (2024), against an average of -$7204.2.
- Across the five-year window, EPS (Basic) surged 99.8% in 2025 and dropped 3.28% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$19073.3 in 2022, then soared by 73.1% to -$5130.9 in 2023, then jumped by 99.41% to -$30.02 in 2024, then surged by 81.64% to -$5.51 in 2025, then jumped by 46.8% to -$2.93 in 2026.
- Per Business Quant, the three latest TNXP EPS (Basic) figures stand at -$2.93 (Q1 2026), -$5.51 (Q4 2025), and -$3.59 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,933.35 Bn | 1,933.29 Bn | - | - |
| 3 | Akari Therapeutics | 1,063.56 Bn | 1,063.56 Bn | - | 0.00 |
| 4 | BeOne Medicines | 468.54 Bn | 463.75 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.20 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 70.42 Bn | 61.67 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 63.57 Bn | 63.57 Bn | - | 0.00 |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.75 Bn | 34.74 Bn | 959.66 Mn | 1.55 |
| 10 | Tonix Pharmaceuticals Holding | 140.70 Mn | 140.70 Mn | 5.30 Mn | -2.93 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.93 |
| Dec 31, 2025 | -5.51 |
| Sep 30, 2025 | -3.59 |
| Jun 30, 2025 | -3.86 |
| Mar 31, 2025 | -2.84 |
| Dec 31, 2024 | -30.02 |
| Sep 30, 2024 | -22.88 |
| Jun 30, 2024 | -1,928.37 |
| Mar 31, 2024 | -591.06 |
| Dec 31, 2023 | -5,130.89 |
| Sep 30, 2023 | -5,840.29 |
| Jun 30, 2023 | -8,571.95 |
| Mar 31, 2023 | -10,418.24 |
| Dec 31, 2022 | -19,073.31 |
| Sep 30, 2022 | -13,820.22 |
| Jun 30, 2022 | -24,459.82 |
| Mar 31, 2022 | -32,564.95 |
| Dec 31, 2021 | -52,492.01 |
| Sep 30, 2021 | -32,335.08 |
| Jun 30, 2021 | -45,469.11 |